Prof. Chris Goetz, co-creator of the MDS-UPDRS, is a leading expert in movement disorder pharmacology and rating-scale development. He is a professor in the Department of Neurological Sciences and ...

AC Immune (NASDAQ:ACIU) surged 25% on Thursday after announcing promising interim Phase 2 findings for its experimental ...

Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...

Shares of AC Immune rose by double-digits on news that the company, encouraged by new data, now intends to ask drug ...

Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. Tavapadon, a drug being tested to treat early ...

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...

We've already seen a pen that helps people with Parkinson's disease to write clearly, but this one is a little different. By assessing its user's hand movements as they write, it can provide an early ...

Alabama's voice in the fight against Parkinson's disease is being heard on both national and international stages, thanks to the Parkinson Association of Alabama's (PAA) leadership within the ...

They observe how a Parkinson's protein pierces neuronal membranes, revealing a gradual attack that could open up new ...

A high-fidelity driving simulator detected subtle visuospatial, attentional, and reaction time impairments in people with ...